DeutschNewstral
Article
Mmarketwatch.com on 2020-01-20 08:58
AstraZeneca: FDA gives orphan drug status to two liver cancer drugs
Related news
Lundbeck's Carnexiv gets FDA orphan drug statusdailyherald.com
FDA Approving Orphan Drugs At A Record Pacejdsupra.com
FDA adds liver warning to AbbVie hepatitis C drugswkrg.com
FDA warns of deadly liver damage with AbbVie hepatitis drugsdothaneagle.com
Annovis Bio seeks orphan drug status from FDA for its lead new drug candidatebizjournals.com
FDA panel wants heart failure risk on AstraZeneca drugsjournalrecord.com
Orphan Drugs Are Your FriendMother Jones- SA biotech gets FDA orphan drug designationbizjournals.com
Orphan drugs for rare diseases soarBoston Herald- FDA finalizes guidance on Orphan Drug “sameness” of gene therapiesjdsupra.com
Sapience Therapeutics ST-36 receives orphan drug designation from FDAwestfaironline.com- FDA pilot program could help Wave avoid orphan-drug pitfallsbizjournals.com
- FDA Issues Grants for Clinical Trial Research for Orphan Diseasesjdsupra.com
- MProQR shares rises on FDA orphan drug designationmarketwatch.com
- HIceCure Gets FDA Nod to Treat Tumors in Liver, Kidneyhamodia.com
- MAstraZeneca: FDA wants more data on Roxadustatmarketwatch.com
FDA warns of liver injury from muscle-building supplementKHQ Local News- Albireo gets FDA, European approval for pediatric liver disease drugbizjournals.com
- FDA approves AstraZeneca drug for severe asthmabizjournals.com